Cargando…
Aortic valve disease in diabetes: Molecular mechanisms and novel therapies
Valve disease and particularly calcific aortic valve disease (CAVD) and diabetes (DM) are progressive diseases constituting a global health burden for all aging societies (Progress in Cardiovascular Diseases. 2014;56(6):565: Circulation Research. 2021;128(9):1344). Compared to non‐diabetic individua...
Autores principales: | Manduteanu, Ileana, Simionescu, Dan, Simionescu, Agneta, Simionescu, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505854/ https://www.ncbi.nlm.nih.gov/pubmed/34561944 http://dx.doi.org/10.1111/jcmm.16937 |
Ejemplares similares
-
Inflammation in atherosclerosis: a cause or a result of vascular disorders?
por: Manduteanu, Ileana, et al.
Publicado: (2012) -
VLA4-Enhanced Allogeneic Endothelial Progenitor Cell-Based Therapy Preserves the Aortic Valve Function in a Mouse Model of Dyslipidemia and Diabetes
por: Filippi, Alexandru, et al.
Publicado: (2022) -
Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells
from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in
Aortic Valve Disease
por: Filippi, Alexandru, et al.
Publicado: (2020) -
Diabetes-induced early molecular and functional changes in aortic
heart valves in a murine model of atherosclerosis
por: Tucureanu, Monica Madalina, et al.
Publicado: (2019) -
High Glucose Induced Changes in Human VEC Phenotype in a 3D Hydrogel Derived From Cell-Free Native Aortic Root
por: Cecoltan, Sergiu, et al.
Publicado: (2021)